₹ 14868 / 14 Shares Shares
Minimum Investment
₹1008-1062 per equity share
08 Dec 2025
10 Dec 2025
14
₹ 14868
₹1008-1062
15 Dec 2025
61,71,101 shares(aggregating up to ₹655.37 crore)
₹10 Per Equity Share
14 Shares
14 Shares
Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.
2004
Dr. Kirtikumar Laxmidas Mehta
Corona Remedies Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Retail (min) | ₹1008-1062 | ₹14,868 |
| Retail(max) | ₹1008-1062 | ₹1,93,284 |
| SHNI(min) | ₹1008-1062 | ₹2,08,152 |
| SHNI(max) | ₹1008-1062 | ₹9,96,156 |
| BHNI(min) | ₹1008-1062 | ₹10,11,024 |
For Corona Remedies Limited IPO, eligible investors can apply as Regular.
You’ll need a valid passport, visa, PAN card, overseas address proof, and NRE/NRO bank details.
Only ELSS funds have a 3-year lock-in. Other funds generally allow you to redeem anytime based on NAV.
Yes, KSquare builds dedicated SIP plans focused on medical security so unexpected health expenses don’t affect regular finances.
Not always. While some NFOs may perform well, they lack historical data. KSquare helps evaluate the potential.
KSquare provides investment solutions, tax planning, mutual funds access, and portfolio management tailored specifically for NRIs.
KSquare offers expert support, real-time tracking, flexible options, and a user-friendly platform to grow your wealth steadily.
Yes, NRIs can easily invest in SEBI-registered mutual funds via KSquare using NRE or NRO bank accounts.
You can withdraw 60% of the corpus at retirement tax-free and use 40% to buy an annuity for regular income.